Multiplex antigen microarrays can profile the high titers of autoantibodies found in the biological fluids of patients with many autoimmune diseases, which enables rapid identification of antibody and antigen biomarker sets. The potential applications of this technology for improved diagnosis, prognosis and selection of targeted therapies are reviewed in this article.
